Clinical management of achondroplasia

M J Wright1, M D Irving

  • 1Northern Genetics Service, Institute of Human Genetics, Newcastle upon Tyne Hospitals NHS Foundation Trust, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK. michael.wright@nuth.nhs.uk

Insights

Achondroplasia (a form of dwarfism) presents unique growth patterns and health issues in children, requiring specialized pediatric care. This review outlines common and severe complications, surveillance, and management strategies for achondroplasia.

Area of Science:

  • Pediatrics
  • Genetics
  • Orthopedics

Background:

  • Achondroplasia is the most common skeletal dysplasia causing disproportionate short stature.
  • Children with achondroplasia exhibit distinct developmental and growth trajectories compared to typically growing children.
  • They are susceptible to a range of complications, from common ear infections to severe cervicomedullary compression.

Purpose of the Study:

  • To review the published literature on complications associated with achondroplasia in children.
  • To provide pediatricians with essential knowledge regarding surveillance strategies and treatment options.
  • To present a systematic approach for managing the healthcare needs of children with achondroplasia.

Main Methods:

  • Systematic review of published literature.
  • Analysis of common and severe complications.
  • Development of a management framework for pediatricians.

Main Results:

  • Children with achondroplasia face a spectrum of health issues, including recurrent otitis media and cervicomedullary compression.
  • Effective management necessitates understanding these specific complications.
  • Appropriate surveillance and timely intervention are crucial for optimal outcomes.

Conclusions:

  • Pediatricians require comprehensive knowledge of achondroplasia-related complications for effective patient care.
  • A systematic, knowledge-based approach to surveillance and management is essential.
  • Early identification and treatment of complications can significantly improve the health and development of children with achondroplasia.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...